CSR Program: Bridges to Development | Takeda Pharmaceuticals

Man explaining data shown in phone to multiple people

Innovation and elimination of neglected tropical diseases: maximizing impact for challenging island communities

Providing care and treatment against neglected tropical diseases, empowering communities, training health workers and strengthening health systems

Bridges to Development logo

The Program

Partner: Bridges to Development

Budget: 681 million yen

Term: 3 years

Launch: 2020

Area: Papua New Guinea and Vanuatu

Visit the Bridges to Development websiteGo to https://bridgestodevelopment.org/

Over 1.5 billion people worldwide are affected by neglected tropical diseases (NTD) even though early prevention and treatment are available.  Many hard-to-reach communities of the Pacific islands remain at high risk for NTD infections and carry a disproportionate burden of these diseases. This partnership helps decrease the burden and removes the need for any large-scale interventions against NTDs in the future by eliminating and controlling targeted NTDs (lymphatic filariasis, yaws, leprosy, trachoma, scabies and soil-transmitted helminthiases).

Women receiving medicine

Kids speaking with physician

Have more questions?

Contact us if you'd like more information about our Global CSR Program.